Zhikai Zheng
Overview
Explore the profile of Zhikai Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu X, Zheng Y, Li H, Ma Y, Cao R, Zheng Z, et al.
J Orthop Translat
. 2025 Jan;
50:56-70.
PMID: 39868350
The Translational Potential Of This Article: The development of metabolomics offers possibilities for the treatment of OA. This article reviews the relationship between metabolites associated with chondrocytes and OA. Selectively...
2.
Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, et al.
Signal Transduct Target Ther
. 2024 Sep;
9(1):234.
PMID: 39289339
The glucagon-like peptide-1 (GLP-1) receptor, known as GLP-1R, is a vital component of the G protein-coupled receptor (GPCR) family and is found primarily on the surfaces of various cell types...
3.
Ma Y, Pang Y, Cao R, Zheng Z, Zheng K, Tian Y, et al.
iScience
. 2024 Sep;
27(9):110597.
PMID: 39220257
Articular cartilage degeneration may lead to osteoarthritis (OA) during the aging process, but its underlying mechanism remains unknown. Here, we found that chondrocytes exhibited an energy metabolism shift from glycolysis...
4.
Zheng Z, Wang J, Wu T, He M, Pan Y, Wang J, et al.
Int J Surg
. 2024 Aug;
111(1):1552-1557.
PMID: 39110571
Background: To improve the prognosis of advanced intrahepatic cholangiocarcinoma (iCCA), the authors retrospectively compared the effect and safety of combined hepatic arterial infusion chemotherapy (HAIC), targeted therapy, and immunotherapy with...
5.
Li W, Zheng Z, Wang J, Wu T, Wang J, Pan Y, et al.
J Hepatocell Carcinoma
. 2024 Mar;
11:463-475.
PMID: 38463545
Purpose: The aim of this study was to investigate the efficacy and safety of conversion surgery for advanced hepatocellular carcinoma (HCC) after hepatic arterial infusion chemotherapy (HAIC). Patients And Methods:...
6.
Wu T, Zheng Z, Wang J, He M, Wang J, Pan Y, et al.
J Hepatocell Carcinoma
. 2023 Dec;
10:2133-2145.
PMID: 38058386
Purpose: To assess the clinical value of the pretherapeutic systemic inflammation score (SIS) in predicting the prognosis of hepatocellular carcinoma (HCC) after hepatic arterial infusion chemotherapy (HAIC). Methods: From February...
7.
Zheng Z, Wang J, Wu T, He M, Wang J, Pan Y, et al.
J Hepatocell Carcinoma
. 2023 Dec;
10:2117-2132.
PMID: 38053944
Purpose: The efficacy of entecavir (ETV) versus tenofovir (TDF) on the prognosis of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients who underwent FOLFOX-hepatic arterial infusion chemotherapy (HAIC) remains unclear....
8.
Wang J, Zheng Z, Wu T, Li W, Wang J, Pan Y, et al.
J Hepatocell Carcinoma
. 2022 Sep;
9:999-1010.
PMID: 36132426
Objective: To evaluate whether surgery-related complications are increased after hepatic arterial infusion chemotherapy (HAIC) using oxaliplatin plus fluorouracil/leucovorin for conversion compared with primary hepatocellular carcinoma (HCC) resection and the optimal...
9.
Li Y, Song Y, Xu W, Li Q, Wang X, Li K, et al.
Sci Adv
. 2020 Jul;
6(24):eaba0777.
PMID: 32704541
R-loops modulate genome stability and regulate gene expression, but the functions and the regulatory mechanisms of R-loops in stem cell biology are still unclear. Here, we profiled R-loops during somatic...